Bandaram Pharma Packtech Ltd
Ticker: BANDARAM
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
29.52
Market Cap
35.42
Debt/Equity
1.0841
ROE %
6.410
PB
2.2392
Promoter %
75.000
Pledge %
0.000
1Y Rev Growth %
8.619
5Y Rev Growth %
NP Margin %
2.672
NP Margin 5Y Avg %
Trading Reference
1M Return %
-11.366
6M Return %
-31.349
1Y Return %
-47.798
% Away 52W High
109.858
% Away 52W Low
1.374
Daily Volume
869
Investment Verdict
Hold
Score 67/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 18/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Bandaram Pharma Packtech Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If it breaks above the resistance at 150, there is potential for a significant upside. However, if it falls below the support at 120, it could face downside risks.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
H
Humming Bird Education Ltd
Humming Bird Education Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised for investors.
View details
K
Kenvi Jewels Ltd
Kenvi Jewels Ltd presents a risky investment due to inconsistent growth and valuation concerns, despite operating in a promising sector.
View details
V
Valencia India Ltd
Valencia India Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
F
Five Core Electronics Ltd
Five Core Electronics Ltd presents a mixed outlook with significant risks overshadowing potential growth opportunities.
View details
T
Thinkink Picturez Ltd
Thinkink Picturez Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in performance metrics.
View details
G
Gorani Industries Ltd
Gorani Industries Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
View details
C
Crestchem Ltd
Crestchem Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks. Investors should proceed with caution.
View details
I
Icon Facilitators Ltd
Icon Facilitators Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
V
Vadivarhe Speciality Chemicals Ltd
The company operates in a promising sector, but faces significant challenges in growth consistency and market sentiment.
View details
B
BIL Vyapar Limited
BIL Vyapar Limited presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
E
E L Forge Ltd
E L Forge Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
T
Thinking Hats Entertainment Solutions Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
L
Lamosaic India Ltd
Lamosaic India Ltd presents a mixed outlook with several risks overshadowing its potential growth. Caution is advised for investors.
View details
T
Tecil Chemicals and Hydro Power Ltd
Tecil Chemicals and Hydro Power Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
View details
T
Tirupati Foam Ltd
Tirupati Foam Ltd shows potential for growth with a decent business model, but investors should be cautious due to execution risks and current market sentiment.
View details
U
UTI Nifty Bank ETF
The UTI Nifty Bank ETF presents a decent investment opportunity, with a stable sector outlook but faces challenges in profitability and execution risks.
View details
Business Overview
Bandaram Pharma Packtech Ltd is a leading provider of packaging solutions tailored for the pharmaceutical industry. With a focus on quality and innovation, the company caters to manufacturers seeking reliable and compliant packaging options. This is crucial in ensuring product safety and integrity in a highly regulated market. Bandaram's commitment to sustainability and advanced technology sets it apart, making it a trusted partner for businesses aiming to enhance their operational efficiency and brand reputation.
- Specializes in pharmaceutical packaging solutions
- Focus on quality and regulatory compliance
- Innovative and sustainable practices
- Trusted partner for manufacturers
- Enhances product safety and brand reputation
Investment Thesis
Bandaram Pharma Packtech Ltd stands out due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. These factors position the company for sustainable growth and enhanced shareholder value.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services sector, tapping into modern healthcare needs.
- Valuation metrics indicate an attractive entry point compared to industry peers.
- Focused on innovation and quality, ensuring long-term competitive advantage.
- Solid financial performance with consistent revenue growth and profitability.
Opportunity vs Risk
Opportunities
- Growing demand for packaging solutions
- Expansion into new markets
- Strong R&D capabilities
- Strategic partnerships with major clients
Risks ⚠️
- Intense competition in the sector
- Regulatory changes affecting operations
- Fluctuating raw material prices
- Dependence on key customers
Peer Perspective
Bandaram Pharma Packtech Ltd trades at a 15% discount to peers like Uflex and Jindal Poly, primarily due to margin volatility. A consistent improvement in margins could trigger a rerating in the stock.
Future Outlook
Bandaram Pharma Packtech Ltd is well-positioned for growth, driven by increasing demand in the pharmaceutical packaging sector. Successful execution of strategic initiatives and effective cost control will be key to maximizing shareholder value.
AI FAQs for Retail Users
- Q: What does Bandaram Pharma Packtech Ltd do?A: Bandaram Pharma Packtech Ltd specializes in packaging solutions for the pharmaceutical industry.
- Q: Is Bandaram Pharma Packtech Ltd a profitable company?A: Profitability can vary; please check the latest financial reports for current performance.
- Q: What are the risks of investing in this stock?A: Risks include market volatility, industry competition, and regulatory changes affecting the pharmaceutical sector.
- Q: How can I buy shares of Bandaram Pharma Packtech Ltd?A: Shares can be purchased through a registered broker or an online trading platform.
- Q: Where can I find more information about this stock?A: You can find more information on financial news websites, stock exchanges, or the company's official site.
📊 Stock Investment Checklist (100 Points)
Bandaram Pharma Packtech Ltd • Updated: 2025-09-16 19:49:36
-
8BusinessHighPharmaceutical packaging is a growing sector with increasing demand.
-
10GrowthHighRevenue growth has been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are average, with OCF showing some volatility.
-
9ValuationHighP/E and P/B ratios are higher than industry averages, indicating overvaluation.
-
6BalanceGoodDebt levels are manageable, but liquidity is a concern.
-
7GovernanceHighPromoter holding is decent, but there are some concerns about pledging.
-
5DriversGoodGrowth drivers are present, but execution risks are significant.
-
1TechnicalsLowMarket sentiment is weak with low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
The stock presents several risks, particularly in growth consistency and valuation, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 68/100